Structure

Physi-Chem Properties

Molecular Weight:  316.06
Volume:  300.063
LogP:  2.76
LogD:  2.155
LogS:  -4.036
# Rotatable Bonds:  3
TPSA:  117.2
# H-Bond Aceptor:  7
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.486
Synthetic Accessibility Score:  2.626
Fsp3:  0.125
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.988
MDCK Permeability:  7.62014542488032e-06
Pgp-inhibitor:  0.003
Pgp-substrate:  0.133
Human Intestinal Absorption (HIA):  0.65
20% Bioavailability (F20%):  0.029
30% Bioavailability (F30%):  0.989

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.028
Plasma Protein Binding (PPB):  89.0607681274414%
Volume Distribution (VD):  0.878
Pgp-substrate:  12.478191375732422%

ADMET: Metabolism

CYP1A2-inhibitor:  0.965
CYP1A2-substrate:  0.732
CYP2C19-inhibitor:  0.155
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.702
CYP2C9-substrate:  0.827
CYP2D6-inhibitor:  0.653
CYP2D6-substrate:  0.256
CYP3A4-inhibitor:  0.38
CYP3A4-substrate:  0.111

ADMET: Excretion

Clearance (CL):  3.199
Half-life (T1/2):  0.865

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.108
Drug-inuced Liver Injury (DILI):  0.942
AMES Toxicity:  0.532
Rat Oral Acute Toxicity:  0.01
Maximum Recommended Daily Dose:  0.034
Skin Sensitization:  0.537
Carcinogencity:  0.025
Eye Corrosion:  0.008
Eye Irritation:  0.953
Respiratory Toxicity:  0.066

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC281272

Natural Product ID:  NPC281272
Common Name*:   Sydowinin B
IUPAC Name:   methyl 2,8-dihydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate
Synonyms:   Sydowinin B
Standard InCHIKey:  SSBSKLSIZKVBFF-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H12O7/c1-22-16(21)13-8(18)2-3-10-14(13)15(20)12-9(19)4-7(6-17)5-11(12)23-10/h2-5,17-19H,6H2,1H3
SMILES:  COC(=O)c1c(ccc2c1c(=O)c1c(cc(cc1o2)CO)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1812029
PubChem CID:   45359153
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[18505285]
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21718031]
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[23647825]
NPO31451 Aspergillus sydowii Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[24057165]
NPO40032 Aspergillus austroafricanus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[27070198]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 85.03 % PMID[572575]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 12620.0 nM PMID[572575]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 66.25 % PMID[572575]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 21200.0 nM PMID[572575]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC281272 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9795 High Similarity NPC39819
0.94 High Similarity NPC135522
0.9392 High Similarity NPC70764
0.9388 High Similarity NPC71055
0.9205 High Similarity NPC474843
0.92 High Similarity NPC470107
0.9195 High Similarity NPC5537
0.9195 High Similarity NPC228012
0.9156 High Similarity NPC186113
0.911 High Similarity NPC145673
0.9091 High Similarity NPC44199
0.9073 High Similarity NPC202595
0.9073 High Similarity NPC295036
0.8993 High Similarity NPC469764
0.8981 High Similarity NPC473961
0.8973 High Similarity NPC18457
0.8954 High Similarity NPC473967
0.8954 High Similarity NPC273483
0.8954 High Similarity NPC175978
0.8947 High Similarity NPC227122
0.894 High Similarity NPC2569
0.894 High Similarity NPC172329
0.8933 High Similarity NPC469758
0.8933 High Similarity NPC211565
0.8933 High Similarity NPC300540
0.8896 High Similarity NPC477691
0.8882 High Similarity NPC241874
0.8875 High Similarity NPC234331
0.8859 High Similarity NPC310340
0.8854 High Similarity NPC143050
0.8846 High Similarity NPC477833
0.8839 High Similarity NPC237560
0.8831 High Similarity NPC253904
0.8831 High Similarity NPC217447
0.8831 High Similarity NPC40356
0.8831 High Similarity NPC477690
0.8831 High Similarity NPC154683
0.8831 High Similarity NPC321363
0.8824 High Similarity NPC255641
0.8824 High Similarity NPC147735
0.8824 High Similarity NPC290954
0.8824 High Similarity NPC294646
0.8812 High Similarity NPC29160
0.8808 High Similarity NPC267509
0.8808 High Similarity NPC60389
0.88 High Similarity NPC113770
0.88 High Similarity NPC274085
0.88 High Similarity NPC89664
0.879 High Similarity NPC329091
0.8782 High Similarity NPC146211
0.8774 High Similarity NPC280530
0.8774 High Similarity NPC95842
0.8774 High Similarity NPC178964
0.8766 High Similarity NPC72958
0.8766 High Similarity NPC232645
0.8766 High Similarity NPC46564
0.8766 High Similarity NPC207346
0.8758 High Similarity NPC233267
0.8758 High Similarity NPC266499
0.8758 High Similarity NPC291049
0.8758 High Similarity NPC76647
0.8758 High Similarity NPC225419
0.875 High Similarity NPC46941
0.8742 High Similarity NPC134621
0.8742 High Similarity NPC303185
0.8742 High Similarity NPC184649
0.8742 High Similarity NPC32470
0.8742 High Similarity NPC311144
0.8733 High Similarity NPC169479
0.8733 High Similarity NPC73028
0.8733 High Similarity NPC159855
0.8733 High Similarity NPC476473
0.8726 High Similarity NPC263483
0.8725 High Similarity NPC275734
0.8725 High Similarity NPC124365
0.8718 High Similarity NPC326910
0.8718 High Similarity NPC175192
0.8716 High Similarity NPC268691
0.871 High Similarity NPC75069
0.871 High Similarity NPC271681
0.871 High Similarity NPC87708
0.8704 High Similarity NPC99613
0.8704 High Similarity NPC165979
0.8704 High Similarity NPC163130
0.8704 High Similarity NPC49487
0.8701 High Similarity NPC213382
0.8701 High Similarity NPC164527
0.8701 High Similarity NPC37348
0.8701 High Similarity NPC225129
0.8701 High Similarity NPC325983
0.8701 High Similarity NPC119929
0.8696 High Similarity NPC30027
0.8693 High Similarity NPC37135
0.8693 High Similarity NPC7025
0.8693 High Similarity NPC191634
0.8693 High Similarity NPC105415
0.8693 High Similarity NPC186397
0.8693 High Similarity NPC256672
0.8693 High Similarity NPC27221
0.8688 High Similarity NPC197168
0.8688 High Similarity NPC474350
0.8684 High Similarity NPC163846
0.8684 High Similarity NPC225173
0.8684 High Similarity NPC196114
0.8684 High Similarity NPC237208
0.8684 High Similarity NPC299011
0.8679 High Similarity NPC474187
0.8679 High Similarity NPC24761
0.8675 High Similarity NPC95123
0.8675 High Similarity NPC66404
0.8671 High Similarity NPC477692
0.8667 High Similarity NPC474300
0.8667 High Similarity NPC105648
0.8667 High Similarity NPC250755
0.8662 High Similarity NPC154341
0.8654 High Similarity NPC169990
0.8654 High Similarity NPC299435
0.8654 High Similarity NPC210942
0.8654 High Similarity NPC472799
0.8654 High Similarity NPC89474
0.8654 High Similarity NPC260604
0.865 High Similarity NPC474004
0.8645 High Similarity NPC149526
0.8645 High Similarity NPC474417
0.8645 High Similarity NPC470569
0.8645 High Similarity NPC70016
0.8645 High Similarity NPC478148
0.8645 High Similarity NPC215921
0.8645 High Similarity NPC202157
0.8645 High Similarity NPC133856
0.8645 High Similarity NPC117579
0.8636 High Similarity NPC158338
0.8636 High Similarity NPC4423
0.8636 High Similarity NPC97029
0.8636 High Similarity NPC285527
0.8636 High Similarity NPC106334
0.8636 High Similarity NPC77325
0.8636 High Similarity NPC288036
0.8636 High Similarity NPC73236
0.8636 High Similarity NPC200221
0.8636 High Similarity NPC97028
0.8636 High Similarity NPC65589
0.8636 High Similarity NPC223988
0.8636 High Similarity NPC294502
0.8636 High Similarity NPC100985
0.8634 High Similarity NPC25361
0.8634 High Similarity NPC112981
0.8634 High Similarity NPC178281
0.8627 High Similarity NPC126767
0.8627 High Similarity NPC190648
0.8627 High Similarity NPC22005
0.8627 High Similarity NPC125801
0.8627 High Similarity NPC308200
0.8627 High Similarity NPC289042
0.8627 High Similarity NPC7943
0.8627 High Similarity NPC146884
0.8627 High Similarity NPC56433
0.8627 High Similarity NPC312929
0.8627 High Similarity NPC245584
0.8627 High Similarity NPC123202
0.8627 High Similarity NPC118027
0.8618 High Similarity NPC131766
0.8618 High Similarity NPC29577
0.8616 High Similarity NPC475886
0.8616 High Similarity NPC119224
0.8616 High Similarity NPC474287
0.8614 High Similarity NPC477682
0.8614 High Similarity NPC477683
0.8609 High Similarity NPC469542
0.8609 High Similarity NPC1534
0.8609 High Similarity NPC472006
0.8609 High Similarity NPC202981
0.8609 High Similarity NPC51106
0.8608 High Similarity NPC165977
0.8608 High Similarity NPC300727
0.8608 High Similarity NPC181960
0.8608 High Similarity NPC241904
0.8608 High Similarity NPC177742
0.8608 High Similarity NPC217677
0.8606 High Similarity NPC289147
0.8606 High Similarity NPC470454
0.8606 High Similarity NPC68381
0.8606 High Similarity NPC199533
0.86 High Similarity NPC182421
0.86 High Similarity NPC220106
0.8599 High Similarity NPC472909
0.8599 High Similarity NPC166054
0.8599 High Similarity NPC89625
0.8599 High Similarity NPC67396
0.8599 High Similarity NPC37392
0.8599 High Similarity NPC149618
0.8599 High Similarity NPC55662
0.8598 High Similarity NPC477836
0.8598 High Similarity NPC158226
0.8591 High Similarity NPC1268
0.859 High Similarity NPC167903
0.8581 High Similarity NPC158866
0.8581 High Similarity NPC475717
0.8581 High Similarity NPC120105
0.8581 High Similarity NPC474660

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC281272 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8654 High Similarity NPD7819 Suspended
0.8649 High Similarity NPD2346 Discontinued
0.8636 High Similarity NPD3226 Approved
0.8581 High Similarity NPD1551 Phase 2
0.8481 Intermediate Similarity NPD5402 Approved
0.8477 Intermediate Similarity NPD3750 Approved
0.84 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD6232 Discontinued
0.8377 Intermediate Similarity NPD2532 Approved
0.8377 Intermediate Similarity NPD2533 Approved
0.8377 Intermediate Similarity NPD2534 Approved
0.8364 Intermediate Similarity NPD5844 Phase 1
0.8355 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD1934 Approved
0.8354 Intermediate Similarity NPD7473 Discontinued
0.8344 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD1549 Phase 2
0.8333 Intermediate Similarity NPD6959 Discontinued
0.8302 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD2801 Approved
0.8261 Intermediate Similarity NPD3749 Approved
0.8258 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8212 Intermediate Similarity NPD2935 Discontinued
0.8176 Intermediate Similarity NPD7411 Suspended
0.8148 Intermediate Similarity NPD7075 Discontinued
0.8146 Intermediate Similarity NPD3748 Approved
0.8146 Intermediate Similarity NPD1510 Phase 2
0.8133 Intermediate Similarity NPD1607 Approved
0.8117 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8113 Intermediate Similarity NPD6599 Discontinued
0.8107 Intermediate Similarity NPD6559 Discontinued
0.8103 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD7768 Phase 2
0.8077 Intermediate Similarity NPD1511 Approved
0.8075 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD5403 Approved
0.8037 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD5401 Approved
0.8025 Intermediate Similarity NPD3817 Phase 2
0.8012 Intermediate Similarity NPD8313 Approved
0.8012 Intermediate Similarity NPD8312 Approved
0.8 Intermediate Similarity NPD4380 Phase 2
0.8 Intermediate Similarity NPD1240 Approved
0.7987 Intermediate Similarity NPD2313 Discontinued
0.7975 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1512 Approved
0.7974 Intermediate Similarity NPD2796 Approved
0.7974 Intermediate Similarity NPD6100 Approved
0.7974 Intermediate Similarity NPD6099 Approved
0.7964 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD6166 Phase 2
0.7964 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD6799 Approved
0.7939 Intermediate Similarity NPD5494 Approved
0.7911 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD6801 Discontinued
0.7891 Intermediate Similarity NPD1203 Approved
0.7882 Intermediate Similarity NPD7074 Phase 3
0.787 Intermediate Similarity NPD3818 Discontinued
0.7866 Intermediate Similarity NPD3882 Suspended
0.7853 Intermediate Similarity NPD1465 Phase 2
0.7844 Intermediate Similarity NPD5710 Approved
0.7844 Intermediate Similarity NPD5711 Approved
0.7829 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD7054 Approved
0.78 Intermediate Similarity NPD4625 Phase 3
0.7799 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD2799 Discontinued
0.7792 Intermediate Similarity NPD4308 Phase 3
0.7778 Intermediate Similarity NPD7472 Approved
0.7771 Intermediate Similarity NPD4628 Phase 3
0.777 Intermediate Similarity NPD1470 Approved
0.7765 Intermediate Similarity NPD3751 Discontinued
0.7748 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD411 Approved
0.7733 Intermediate Similarity NPD6797 Phase 2
0.7733 Intermediate Similarity NPD6832 Phase 2
0.7719 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD447 Suspended
0.7707 Intermediate Similarity NPD2800 Approved
0.7707 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD920 Approved
0.7688 Intermediate Similarity NPD7251 Discontinued
0.7687 Intermediate Similarity NPD9717 Approved
0.7663 Intermediate Similarity NPD7435 Discontinued
0.7651 Intermediate Similarity NPD2797 Approved
0.7644 Intermediate Similarity NPD7808 Phase 3
0.7632 Intermediate Similarity NPD3268 Approved
0.7632 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD5953 Discontinued
0.7619 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD1201 Approved
0.7596 Intermediate Similarity NPD6781 Approved
0.7596 Intermediate Similarity NPD6776 Approved
0.7596 Intermediate Similarity NPD6777 Approved
0.7596 Intermediate Similarity NPD6782 Approved
0.7596 Intermediate Similarity NPD6779 Approved
0.7596 Intermediate Similarity NPD6778 Approved
0.7596 Intermediate Similarity NPD6780 Approved
0.7584 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD2344 Approved
0.7578 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD6844 Discontinued
0.7576 Intermediate Similarity NPD37 Approved
0.7571 Intermediate Similarity NPD8150 Discontinued
0.7568 Intermediate Similarity NPD1608 Approved
0.7564 Intermediate Similarity NPD7033 Discontinued
0.7545 Intermediate Similarity NPD4967 Phase 2
0.7545 Intermediate Similarity NPD4965 Approved
0.7545 Intermediate Similarity NPD4966 Approved
0.7532 Intermediate Similarity NPD4307 Phase 2
0.7529 Intermediate Similarity NPD3787 Discontinued
0.7517 Intermediate Similarity NPD4749 Approved
0.7516 Intermediate Similarity NPD7390 Discontinued
0.7516 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD5406 Approved
0.7516 Intermediate Similarity NPD3764 Approved
0.7516 Intermediate Similarity NPD5408 Approved
0.7516 Intermediate Similarity NPD5404 Approved
0.7516 Intermediate Similarity NPD5405 Approved
0.7514 Intermediate Similarity NPD7286 Phase 2
0.75 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD4908 Phase 1
0.7485 Intermediate Similarity NPD4288 Approved
0.7484 Intermediate Similarity NPD1243 Approved
0.7484 Intermediate Similarity NPD1933 Approved
0.7483 Intermediate Similarity NPD2798 Approved
0.7473 Intermediate Similarity NPD7696 Phase 3
0.7473 Intermediate Similarity NPD7697 Approved
0.7473 Intermediate Similarity NPD7698 Approved
0.7472 Intermediate Similarity NPD8434 Phase 2
0.7456 Intermediate Similarity NPD6234 Discontinued
0.7453 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7433 Intermediate Similarity NPD7871 Phase 2
0.7433 Intermediate Similarity NPD7870 Phase 2
0.7427 Intermediate Similarity NPD7229 Phase 3
0.7423 Intermediate Similarity NPD6273 Approved
0.7421 Intermediate Similarity NPD7874 Approved
0.7421 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD1613 Approved
0.7419 Intermediate Similarity NPD6823 Phase 2
0.7417 Intermediate Similarity NPD3266 Approved
0.7417 Intermediate Similarity NPD3267 Approved
0.741 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD2309 Approved
0.7383 Intermediate Similarity NPD1611 Approved
0.7383 Intermediate Similarity NPD422 Phase 1
0.7382 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD7783 Phase 2
0.7372 Intermediate Similarity NPD230 Phase 1
0.7368 Intermediate Similarity NPD1019 Discontinued
0.7368 Intermediate Similarity NPD8151 Discontinued
0.7368 Intermediate Similarity NPD7199 Phase 2
0.7368 Intermediate Similarity NPD1247 Approved
0.7365 Intermediate Similarity NPD17 Approved
0.7356 Intermediate Similarity NPD7228 Approved
0.7356 Intermediate Similarity NPD7177 Discontinued
0.7353 Intermediate Similarity NPD919 Approved
0.7351 Intermediate Similarity NPD1283 Approved
0.7351 Intermediate Similarity NPD3225 Approved
0.7345 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD9493 Approved
0.7329 Intermediate Similarity NPD7003 Approved
0.7322 Intermediate Similarity NPD6534 Approved
0.7322 Intermediate Similarity NPD6535 Approved
0.732 Intermediate Similarity NPD2861 Phase 2
0.7316 Intermediate Similarity NPD7701 Phase 2
0.7315 Intermediate Similarity NPD3496 Discontinued
0.731 Intermediate Similarity NPD6746 Phase 2
0.7308 Intermediate Similarity NPD943 Approved
0.7293 Intermediate Similarity NPD4287 Approved
0.7283 Intermediate Similarity NPD3926 Phase 2
0.7273 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD5124 Phase 1
0.725 Intermediate Similarity NPD1471 Phase 3
0.7248 Intermediate Similarity NPD1778 Approved
0.723 Intermediate Similarity NPD1548 Phase 1
0.7229 Intermediate Similarity NPD1653 Approved
0.7219 Intermediate Similarity NPD1481 Phase 2
0.7211 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD7699 Phase 2
0.7204 Intermediate Similarity NPD7700 Phase 2
0.7202 Intermediate Similarity NPD7801 Approved
0.7197 Intermediate Similarity NPD4060 Phase 1
0.7197 Intermediate Similarity NPD2979 Phase 3
0.7184 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD7985 Registered
0.7174 Intermediate Similarity NPD6212 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data